The oral drug by Merck & Co. smashes all competitors for the treatment and prevention of atherosclerosis.
Precision BioSciences
Posted inNew Drugs, Oncology, Rare/Orphan Diseases, Regulatory
Tecvayli: New Drug for Multiple Myeloma
Teclistamab by Johnson & Johnson is a new hope for refractory or relapsing multiple myeloma.